Kl. Klette et al., NEUROPROTECTIVE SIGMA-LIGANDS ATTENUATE NMDA AND TRANS-ACPD-INDUCED CALCIUM SIGNALING IN RAT PRIMARY NEURONS, Brain research, 756(1-2), 1997, pp. 231-240
The effect of neuroprotective sigma ligands possessing a range of rela
tive selectivity for sigma and phencyclidine (PCP) binding sites on N-
methyl-D-aspartate (NMDA) and (+/-)-1-aminocyclopentane-trans-1,3-dica
rboxylic acid (trans-ACPD)-stimulated calcium flux was studied in 12-1
5-day-old primary cultures of rat cortical neurons. In approximately 8
0% of the neurons tested, NMDA (80 mu M) caused a sustained increase i
n intracellular calcium ([Ca2+](i)). With the exception of R-(+)-3-(3-
hydroxyphenyl)-N-propylpiperidine hydrochloride ((+)-3-PPP) (previousl
y shown not to be neuroprotective) all of the sigma ligands studied si
gnificantly altered NMDA-induced calcium dynamics. The primary effect
of dextromethorphan, (+)-pentazocine, (+)-cyclazocine, (+)-SKF10047, c
arbetapentane, 1,3-di(2-tolyl) guanidine (DTG), and haloperidol was to
shift the NMDA response from a sustained, to either a biphasic or a t
ransient, calcium event. In contrast to NMDA, the primary response obs
erved in 62% of the neurons treated with trans-ACPD (100 mu M) was a t
ransient elevation in [Ca2+](i). Here, however, only the highly select
ive neuroprotective sigma ligands (i.e., those lacking substantial PCP
binding affinity) significantly decreased the number of transient res
ponses elicited by trans-ACPD whereas the PCP-related sigma ligands su
ch as dextromethorphan, (+)-SKF10047 and (+)-cyclazocine were ineffect
ive. Unexpectedly, (+)-3-PPP potentiated trans-ACPD activity. These re
sults demonstrating attenuating effects of sigma ligands on NMDA-stimu
lated neuronal calcium responses agree with earlier studies using glut
amate and KCl and identify a sigma receptor modulation of functional N
MDA responsiveness. Furthermore, the ability of sigma ligands to atten
uate NMDA-, trans-ACPD- and KCl-evoked neuronal calcium dynamics indic
ates that the receptor mechanisms mediating sigma neuroprotection comp
rise complex interactions involving ionotropic, metabotropic, and even
voltage-gated calcium signaling processes.